| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,170 | 1,220 | 09:35 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 29.06. | Mentice AB: Mentice secures $2.4M in several orders from one Top 20 Global MedTech Company in Interventional Cardiology, focused on Structural Heart Disease | 398 | GlobeNewswire (Europe) | Mentice AB (publ), a globally recognized leader in simulation solutions for image-guided therapies, today announced the receipt of two orders in total value of $2.4M from one of the world's top 20 medical... ► Artikel lesen | |
| 01.06. | Mentice AB: Mentice and Siemens Healthineers Announce Co-Marketing Partnership to Advance Neurovascular Treatment Planning | 824 | GlobeNewswire (Europe) | Gothenburg, Sweden - June 2026 - Mentice AB, a global leader in simulation and clinical decision support solutions for Image-Guided Therapies, today announced a co-marketing agreement with Siemens Healthineers... ► Artikel lesen | |
| MENTICE Aktie jetzt für 0€ handeln | |||||
| 07.05. | Mentice AB: Interim Report Jan-mar 2026 | 226 | GlobeNewswire (Europe) | CONTINUED MOMENTUM AND STRONG ORGANIC GROWTH
Significant events during the FIRST quarter 2026 (JAN - MAR)Order intake and revenues increased significantly during the quarter and Order Intake amounted... ► Artikel lesen | |
| 23.03. | Mentice AB: Mentice Appoints Rick van Veen as Chief Financial Officer and Announces Changes to the Executive Management Group | 162 | GlobeNewswire (Europe) | Mentice AB (publ), Gothenburg, Sweden - Mentice today announced the appointment of Rick van Veen as Chief Financial Officer, effective July 1, 2026. Rick brings extensive experience in financial management... ► Artikel lesen | |
| 26.02. | Mentice AB: Communique from extraordinary shareholders' meeting in Mentice AB | 179 | GlobeNewswire (Europe) | An extraordinary shareholders' meeting was held in Mentice AB ("the Company") on February 26, 2026. Below follows a summary of the resolutions made at the meeting.
Resolution on the number of board... ► Artikel lesen | |
| 26.02. | Mentice AB Reports Increase In Q4 Income | - | RTTNews | ||
| 26.02. | Mentice AB: Mentice publishes the company's year-end report for the period January-December 2025 | 192 | GlobeNewswire (Europe) | STRONG ORGANIC GROWTH AND RESULT IMPROVEMENT DESPITE CURRENCY HEADWINDS
SIGNIFICANT EVENTS DURING THE FOURTH QUARTER 2025 (OCT - DEC)Order intake increased significantly during the quarter and amounted... ► Artikel lesen | |
| 08.12.25 | Bure Equity AB: Bure divests holding in Mentice | 410 | GlobeNewswire (Europe) | Bure Equity AB (publ) ("Bure") has signed an agreement to divest 4,037,824 shares in Mentice AB (publ), listed on Nasdaq First North Growth Market.
The buyer is Gulf Offshore Limited, a company controlled... ► Artikel lesen | |
| 06.11.25 | Mentice AB: Mentice publishes the company's interim report for the period July - September 2025 | 268 | GlobeNewswire (Europe) | SIGNIFICANT PROGRESS IN PERFORMANCE AS MARKET ACTIVITY INCREASES
SIGNIFICANT EVENTS DURING THE THIRD QUARTER 2025 (Jul - Sep)• The strategic organizational change announced in June, aimed at aligning... ► Artikel lesen | |
| 21.08.25 | Mentice AB: Mentice receives approximately SEK 31.95 million through oversubscribed rights issue | 266 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA... ► Artikel lesen | |
| 01.08.25 | Mentice AB: Mentice receives an additional Subscription Commitment of 3.4 MSEK in the upcoming Rights Issue | 258 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA... ► Artikel lesen | |
| 31.07.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 31.07.2025 | 508 | Xetra Newsboard | Das Instrument MN2 SE0012673291 MENTICE AB SK -,20 EQUITY wird ex Kapitalmassnahme gehandelt am 31.07.2025 The instrument MN2 SE0012673291 MENTICE AB SK -,20 EQUITY is traded ex capital adjustment on... ► Artikel lesen | |
| 24.07.25 | Mentice AB: Mentice resolves on a rights issue of approximately SEK 31.95 million | 328 | GlobeNewswire (Europe) | The Board of Directors of Mentice AB (publ) ("Mentice" or the "Company"), (Nasdaq First North Premium Growth Market) has today, based on the authorization granted by the annual general meeting on 27... ► Artikel lesen | |
| 24.07.25 | Mentice AB: Mentice publishes the company's interim report for the period April-June 2025 | 291 | GlobeNewswire (Europe) | IMPORTANT STRATEGIC STEPS TAKEN
SIGNIFICANT EVENTS DURING THE SECOND QUARTER 2025 (APR - JUN)Mentice announced a strategic workforce realignment aimed at optimizing its organizational structure and... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 14,320 | -0,76 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| PENUMBRA | 276,80 | 0,00 % | Penumbra, Inc.: First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke | ALAMEDA, Calif., July 7, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced the initiation of its FORWARD study, an international, real... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 69,68 | +0,01 % | Raymond James initiates BrightSpring Health stock with outperform rating | ||
| BILLIONTOONE | 124,59 | -0,22 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,210 | +0,05 % | Kaplan Fox & Kilsheimer LLP: Kaplan Fox Alerts Investors of Alignment Healthcare, Inc. (ALHC) to an Investigation of Potential Securities Law Violations | New York, New York--(Newsfile Corp. - July 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or... ► Artikel lesen | |
| BETA BIONICS | 16,860 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| GENEDX | 62,37 | -0,10 % | Piper Sandler raises GeneDx stock price target on coverage policy | ||
| HEARTFLOW | 25,500 | +0,04 % | Heartflow, Inc.: New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management | ||
| ADAPTHEALTH | 10,190 | 0,00 % | AdaptHealth Flags Material Breach After Threat Actor Accessed Patient Management Systems | ||
| PROCEPT BIOROBOTICS | 19,300 | -0,05 % | PROCEPT BioRobotics to Report Second Quarter 2026 Financial Results on August 4th, 2026 | ||
| PROGYNY | 32,360 | 0,00 % | KeyBanc raises Progyny stock price target on utilization strength | ||
| LIFESTANCE HEALTH GROUP | 10,795 | +0,05 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 28,030 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 9,350 | +0,11 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Completes Acquisition of Family First Homecare and Updates Full Year 2026 Guidance | ATLANTA, June 02, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen | |
| ONCOLOGY INSTITUTE | 6,290 | +0,16 % | BTIG hebt Kursziel für Oncology Institute Aktie nach Umschuldung auf 9 US-Dollar an |